Home

Forge Dosta Odbaciti p tau površinski sramotan raskorak

Disrupted ubiquitin proteasome system underlying tau accumulation in  Alzheimer's disease - ScienceDirect
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect

JCI - CHIP-ping away at tau
JCI - CHIP-ping away at tau

Frontiers | Pathological Tau From Alzheimer's Brain Induces Site-Specific  Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of  Tau in vivo
Frontiers | Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo

Polymerization of hyperphosphorylated tau into filaments eliminates its  inhibitory activity | PNAS
Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity | PNAS

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the  association of amyloid with tau | EMBO Molecular Medicine
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau | EMBO Molecular Medicine

Phosphorylated tau targeted small-molecule PROTACs for the treatment of  Alzheimer's disease and tauopathies - ScienceDirect
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in  Alzheimer's disease and frontotemporal lobar degeneration: a retrospective  diagnostic performance study - The Lancet Neurology
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study - The Lancet Neurology

STZ effect on p-tau in hippocampus. (a) Representative immunoblots of... |  Download Scientific Diagram
STZ effect on p-tau in hippocampus. (a) Representative immunoblots of... | Download Scientific Diagram

Frontiers | CSF p-tau as a potential cognition impairment biomarker in ALS
Frontiers | CSF p-tau as a potential cognition impairment biomarker in ALS

Levels of phospho-tau (P-tau; antibodies AT8 and PHF13) and total tau... |  Download Scientific Diagram
Levels of phospho-tau (P-tau; antibodies AT8 and PHF13) and total tau... | Download Scientific Diagram

Approach - Pinteon Therapeutics
Approach - Pinteon Therapeutics

Phospho-Tau (Ser46) Antibody | Cell Signaling Technology
Phospho-Tau (Ser46) Antibody | Cell Signaling Technology

P-tau subgroups in AD relate to distinct amyloid production and synaptic  integrity profiles | Alzheimer's Research & Therapy | Full Text
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text

Biomarkers in Alzheimer's disease
Biomarkers in Alzheimer's disease

Don't Phos Over Tau”: recent developments in clinical biomarkers and  therapies targeting tau phosphorylation in Alzheimer's disease and other  tauopathies | Molecular Neurodegeneration | Full Text
Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text

Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau  Conformation in Alzheimer's Disease - ScienceDirect
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect

Phospho-tau/tau Ratios: Better Markers than Absolute p-Tau Levels? |  ALZFORUM
Phospho-tau/tau Ratios: Better Markers than Absolute p-Tau Levels? | ALZFORUM

Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's  Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS  Chemical Neuroscience
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience

p-Tau Antibody (PHF-6) | SCBT - Santa Cruz Biotechnology
p-Tau Antibody (PHF-6) | SCBT - Santa Cruz Biotechnology

IJMS | Free Full-Text | Phosphorylated Tau in Alzheimer’s Disease and  Other Tauopathies
IJMS | Free Full-Text | Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

Fluorescence Lifetime Imaging of p-tau Protein in Single Neuron with a  Highly Selective Fluorescent Probe | Analytical Chemistry
Fluorescence Lifetime Imaging of p-tau Protein in Single Neuron with a Highly Selective Fluorescent Probe | Analytical Chemistry

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers,  differential diagnosis, neuropathology and longitudinal progression to  Alzheimer's dementia | Nature Medicine
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker  of Alzheimer's disease | Nature Communications
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications

Cis P-tau underlies vascular contribution to cognitive impairment and  dementia and can be effectively targeted by immunotherapy in mice | Science  Translational Medicine
Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice | Science Translational Medicine

Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer's |  ALZFORUM
Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer's | ALZFORUM